ATA147691A - Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung - Google Patents

Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung

Info

Publication number
ATA147691A
ATA147691A AT0147691A AT147691A ATA147691A AT A147691 A ATA147691 A AT A147691A AT 0147691 A AT0147691 A AT 0147691A AT 147691 A AT147691 A AT 147691A AT A147691 A ATA147691 A AT A147691A
Authority
AT
Austria
Prior art keywords
stabilization
pharmaceutical preparations
ace inhibitor
inhibitor content
content
Prior art date
Application number
AT0147691A
Other languages
English (en)
Other versions
AT400519B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA147691A publication Critical patent/ATA147691A/de
Application granted granted Critical
Publication of AT400519B publication Critical patent/AT400519B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0147691A 1990-07-25 1991-07-24 Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung AT400519B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (2)

Publication Number Publication Date
ATA147691A true ATA147691A (de) 1995-06-15
AT400519B AT400519B (de) 1996-01-25

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0147691A AT400519B (de) 1990-07-25 1991-07-24 Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung

Country Status (30)

Country Link
EP (1) EP0468929B1 (de)
JP (1) JP2502849B2 (de)
KR (1) KR100227156B1 (de)
AT (1) AT400519B (de)
AU (1) AU639354B2 (de)
CA (1) CA2047802C (de)
CH (1) CH683150A5 (de)
CZ (1) CZ280184B6 (de)
DE (1) DE4124409B4 (de)
DK (1) DK0468929T3 (de)
ES (1) ES2061218T3 (de)
FI (1) FI98127C (de)
GB (1) GB2246296B (de)
HU (1) HU222489B1 (de)
IE (1) IE66184B1 (de)
IL (1) IL98934A (de)
IT (1) IT1290797B1 (de)
LU (1) LU87980A1 (de)
MX (1) MX9100357A (de)
MY (1) MY107183A (de)
NO (1) NO912872D0 (de)
NZ (1) NZ239078A (de)
PL (1) PL167712B1 (de)
PT (1) PT98417B (de)
RU (1) RU2075310C1 (de)
SA (1) SA92130106B1 (de)
SK (1) SK278563B6 (de)
TW (1) TW212757B (de)
UA (1) UA26064A1 (de)
ZA (1) ZA915861B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0719280B1 (de) * 1994-07-13 1999-11-10 Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.D. Verfahren zur herstellung von verbindungen mit ace-hemmender wirkung somit neue verbindungen, die nuetzlich als ausgangstoffe sind sowie zwischenverbindungen beim genannten verfahren
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
NZ508544A (en) 1998-06-05 2002-10-25 Warner Lambert Co Angiotensin converting enzyme inhibitors, such as quinapril, enalapril and indolapril, stabilised with 1-90 wt% magnesium oxide
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) † 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
ES2283774T3 (es) * 2002-01-15 2007-11-01 Actavis Group Hf. Formulaciones de quinapril e inhibidores de la eca relacionados.
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (de) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. Pharmazeutische Zusammensetzung enthaltend Perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
MX2019014201A (es) 2017-05-31 2020-01-23 Boehringer Ingelheim Int Composicion farmaceutica y forma de dosificacion farmaceutica que comprenden (e)-4-(2-(aminometil)-3-fluoroaliloxi)-n-ter-butilbenza mida, proceso para su preparacion, metodos de tratamiento y usos de las mismas.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
RU2075310C1 (ru) 1997-03-20
EP0468929B1 (de) 1994-09-28
HUT59819A (en) 1992-07-28
ITRM910554A1 (it) 1993-01-23
KR920002146A (ko) 1992-02-28
PT98417A (pt) 1992-06-30
GB9115893D0 (en) 1991-09-04
MY107183A (en) 1995-09-30
IE912608A1 (en) 1992-01-29
IL98934A0 (en) 1992-07-15
PL291219A1 (en) 1992-08-24
JPH04253923A (ja) 1992-09-09
ZA915861B (en) 1993-03-31
UA26064A1 (uk) 1999-04-30
PT98417B (pt) 1999-01-29
ITRM910554A0 (it) 1991-07-23
SK278563B6 (en) 1997-10-08
IL98934A (en) 1996-07-23
FI913554A0 (fi) 1991-07-24
ES2061218T3 (es) 1994-12-01
FI98127C (fi) 1997-04-25
AU8128691A (en) 1992-01-30
LU87980A1 (fr) 1993-02-15
NO912872D0 (no) 1991-07-23
CH683150A5 (de) 1994-01-31
DK0468929T3 (da) 1994-12-27
DE4124409A1 (de) 1992-01-30
CZ280184B6 (cs) 1995-11-15
CA2047802C (en) 2003-05-06
EP0468929A3 (en) 1992-02-19
AT400519B (de) 1996-01-25
FI98127B (fi) 1997-01-15
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
HU222489B1 (hu) 2003-07-28
SA92130106B1 (ar) 2005-10-16
TW212757B (de) 1993-09-11
JP2502849B2 (ja) 1996-05-29
AU639354B2 (en) 1993-07-22
FI913554A (fi) 1992-01-26
IE66184B1 (en) 1995-12-13
MX9100357A (es) 1992-02-28
PL167712B1 (en) 1995-10-31
HU9102385D0 (en) 1991-12-30
NZ239078A (en) 1993-10-26
CS230991A3 (en) 1992-04-15
DE4124409B4 (de) 2004-11-18
EP0468929A2 (de) 1992-01-29
CA2047802A1 (en) 1992-01-26
IT1290797B1 (it) 1998-12-11
KR100227156B1 (ko) 1999-10-15

Similar Documents

Publication Publication Date Title
BR1100824A (pt) Composto e composição farmacêutica
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
DE69233491D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosolipoproteine und deren Verwendung
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
BR1100329A (pt) Composto e formulação farmacêutica
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
KR950704251A (ko) 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof)
ITMI920408A0 (it) Derivati benzopiranici e benzotiopiranici
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
BR9200058A (pt) Composto e composicao farmaceutica
EE9600139A (et) Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks
BR9604950A (pt) Composição farmacêutica contendo n-clorofenil carbamatos n-clorofeniltiocarbamatos e derivados de n-fosfonoglicina para inibir o crescimento de cânceres e vírus em mamíferos
ATA147691A (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
NZ233122A (en) Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor
DE59407193D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
DK72594A (da) Farmaceutisk præparat med analgerisk virkning indeholdende arginin og (S)-Ibuprofen
DE4294862T1 (de) Pharmazeutische Komposition
DE69415570D1 (de) Esculetin Derivate und pharmazeutische Zusammenstellung
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
DK439589A (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
NO305750B1 (no) Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
DE69800970D1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
MK07 Expiry

Effective date: 20110724